跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amlohope Plus - SFDA Drug Approval Details
Approvals
/
SFDA
/
Amlohope Plus
Authorized
GENERIC
Amlohope Plus
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
574d7b603ec771ff
Company
Unknown
Type
Generic
Approval Details
Approval Id
574d7b603ec771ff
Drug Approval Sfda Name
Amlohope Plus
Trade Name
Amlohope Plus
Generic Name
RAMIPRIL,AMLODIPINE BESILATE,HYDROCHLOROTHIAZIDE
Register Number
2108234013
Register Year
2023
Drug Type
Generic
Route Of Administration
Oral use
Package Type
Blister
Package Size
30
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
do not store above 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
21000001780-45-100000073375
Price
62.8
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
574d7b603ec771ff
Type
Generic
Back to SFDA Approvals